Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
GOVX Stock Forecast 2026-2027
$1.18
Current Price
$6.15M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to GOVX Price Targets
+747.5%
To High Target of $10.00
+747.5%
To Median Target of $10.00
+747.5%
To Low Target of $10.00
GOVX Price Momentum
-7.8%
1 Week Change
-4.1%
1 Month Change
-96.4%
1 Year Change
-72.4%
Year-to-Date Change
-96.6%
From 52W High of $34.75
+22.5%
From 52W Low of $0.96
📊 TOP ANALYST CALLS
Did GOVX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if GeoVax is one of their latest high-conviction picks.
Latest GOVX Stock Price Targets & Analyst Predictions
Based on our analysis of 5 Wall Street analysts, GOVX has a bullish consensus with a median price target of $10.00 (ranging from $10.00 to $10.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $1.18, the median forecast implies a 747.5% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
GOVX Analyst Ratings
2
Buy
0
Hold
0
Sell
GOVX Price Target Range
Low
$10.00
Average
$10.00
High
$10.00
Current: $1.18
Latest GOVX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for GOVX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 16, 2026 | D. Boral Capital | Jason Kolbert | Hold | Maintains | $1.00 |
| Feb 19, 2026 | D. Boral Capital | Hold | Downgrade | $N/A | |
| Jan 21, 2026 | D. Boral Capital | Buy | Maintains | $N/A | |
| Nov 19, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Sep 26, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Aug 7, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Jul 29, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Jul 17, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Jun 16, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| May 2, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Apr 16, 2025 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Apr 15, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Apr 10, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Mar 28, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Feb 27, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Jan 31, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Jan 16, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Dec 18, 2024 | D. Boral Capital | Buy | Maintains | $N/A | |
| Nov 20, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Nov 19, 2024 | D. Boral Capital | Buy | Maintains | $N/A |
Geovax Labs Inc. (GOVX) Competitors
The following stocks are similar to GeoVax based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Geovax Labs Inc. (GOVX) Financial Data
Geovax Labs Inc. has a market capitalization of $6.15M with a P/E ratio of -0.1x. The company generates $852,282 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of -2,523.4% and return on equity of -509.3%.
Valuation Metrics
Market Cap
$6.15M
Enterprise Value
$3.36M
P/E Ratio
-0.1x
PEG Ratio
0.0x
Price/Sales
8.1x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
-2,523.4%
Net Margin
0.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+31.0%
Current Ratio
1.1x
Debt/Equity
79.9x
ROE
-509.3%
ROA
-194.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Geovax Labs Inc. (GOVX) Business Model
About Geovax Labs Inc.
What They Do
Develops vaccines and immunotherapies for diseases.
Business Model
GeoVax Labs Inc. operates as a clinical-stage biotechnology company that generates revenue through the development of innovative vaccines and immunotherapy treatments. The company utilizes its proprietary vaccine platforms to create preventive vaccines for infectious diseases and therapeutic candidates for oncology, aiming to address unmet medical needs in these areas.
Additional Information
Founded in 1988 and headquartered in Smyrna, Georgia, GeoVax focuses on high-consequence pathogens and solid tumor cancers. Its pipeline includes next-generation candidates evaluated through clinical and preclinical programs, highlighting its commitment to public health and the advancement of medical science.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
19
CEO
Mr. David Alan Dodd
Country
United States
IPO Year
2020
Website
www.geovax.comGeovax Labs Inc. (GOVX) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
GeoVax Labs (GOVX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Jun 12, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
GeoVax Labs (GOVX) shows potential for a turnaround as a hammer chart pattern indicates support, alongside upward revisions of earnings estimates by Wall Street analysts.
Why It Matters
GeoVax Labs shows signs of recovery with a hammer chart pattern and upward revisions in earnings estimates by analysts, indicating potential for stock price appreciation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
GeoVax Labs, Inc. (GOVX) is developing a strategy for infectious disease preparedness, targeting Ebola, Marburg, Hantavirus, and Mpox.
Why It Matters
GeoVax's focus on infectious disease preparedness could signal growth potential and increased demand for their vaccines, impacting stock performance and investor confidence in the biotech sector.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
GeoVax Labs, Inc. (NASDAQ:GOVX) is seeing an increase in stock price due to a recent financing deal and heightened interest in its vaccine platform advancements.
Why It Matters
GeoVax's rising stock reflects positive investor sentiment from its financing deal and advancements in vaccine technology, indicating potential for future growth and profitability.
Source: Benzinga
Market Sentiment:
Positive
Quick Summary
GeoVax Labs (GOVX) has been upgraded to a Zacks Rank #2 (Buy), indicating growing optimism about its earnings prospects.
Why It Matters
GeoVax Labs' upgrade to Zacks Rank #2 signals increased confidence in its earnings potential, likely attracting more investor interest and potentially driving the stock price higher.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
GeoVax Labs, Inc. (GOVX) will hold its Q3 2025 earnings call on November 13, 2025, at 4:30 PM EST, featuring company executives and various analysts from research firms.
Why It Matters
The Q3 earnings call for GeoVax Labs provides insights into the company's financial health and strategic direction, impacting stock performance and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
GeoVax Labs (GOVX) has been upgraded to a Zacks Rank #2 (Buy), indicating increased optimism about its earnings prospects, potentially leading to a rise in its stock value.
Why It Matters
GeoVax's upgrade to Zacks Rank #2 signals positive earnings potential, likely boosting investor confidence and increasing demand for its shares.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About GOVX Stock
What is Geovax Labs Inc.'s (GOVX) stock forecast for 2026?
Based on our analysis of 5 Wall Street analysts, Geovax Labs Inc. (GOVX) has a median price target of $10.00. The highest price target is $10.00 and the lowest is $10.00.
Is GOVX stock a good investment in 2026?
According to current analyst ratings, GOVX has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.18. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for GOVX stock?
Wall Street analysts predict GOVX stock could reach $10.00 in the next 12 months. This represents a 747.5% increase from the current price of $1.18. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Geovax Labs Inc.'s business model?
GeoVax Labs Inc. operates as a clinical-stage biotechnology company that generates revenue through the development of innovative vaccines and immunotherapy treatments. The company utilizes its proprietary vaccine platforms to create preventive vaccines for infectious diseases and therapeutic candidates for oncology, aiming to address unmet medical needs in these areas.
What is the highest forecasted price for GOVX Geovax Labs Inc.?
The highest price target for GOVX is $10.00 from at , which represents a 747.5% increase from the current price of $1.18.
What is the lowest forecasted price for GOVX Geovax Labs Inc.?
The lowest price target for GOVX is $10.00 from at , which represents a 747.5% increase from the current price of $1.18.
What is the overall GOVX consensus from analysts for Geovax Labs Inc.?
The overall analyst consensus for GOVX is bullish. Out of 5 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $10.00.
How accurate are GOVX stock price projections?
Stock price projections, including those for Geovax Labs Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 16, 2026 6:55 AM UTC